Shivalik Rasayan Q3FY26 Results Published

Shivalik Rasayan Limited published unaudited financial results for Q3FY26 quarter ended December 31, 2025, approved by Board on February 13, 2026.

Shivalik Rasayan Director's Relative Receives 1.12L Shares

Shivalik Rasayan disclosed that Mrs. Kanchan Sharma, immediate relative of Director Mr. Ashwani Kumar Sharma, received 1,12,000 equity shares as gift under SEBI insider trading regulations.

Shivalik Rasayan Limited Publishes Un-Audited Quarterly Financial Results

Shivalik Rasayan Limited's Board of Directors approved and published the company's un-audited standalone and consolidated financial results for the quarter ended September 30, 2025, at their meeting held on November 14, 2025. The results along with Limited Review Report have been posted on the company's website and published in Financial Express and Vir Arjun newspapers on November 15, 2025.

Shivalik Rasayan Reports Q1 FY2026 Results, Plans Pesticide Formulation Subsidiary

Shivalik Rasayan Limited approved its unaudited financial results for the quarter ended June 30, 2025. The company reported standalone net sales of Rs 4,626.45 lakhs compared to Rs 3,158.11 lakhs in the same quarter last year, with net profit of Rs 122.08 lakhs versus Rs 306.92 lakhs previously. Consolidated revenue reached Rs 8,930.93 lakhs with net profit of Rs 282.13 lakhs. The board approved the incorporation of a wholly-owned subsidiary for manufacturing and marketing pesticide formulations as a forward integration strategy. Other approvals included the annual report for FY2025, cost audit report, and re-designation of Ashwani Kumar Sharma as Non-Executive, Non-Independent Director. The company declared a proposed final dividend of 10% or Rs 0.50 per equity share for FY2025, subject to shareholder approval at the 47th AGM scheduled for September 27, 2025.

Shivalik Rasayan Reports Q4 Financial Results

Shivalik Rasayan has released its Q4 financial results. The company's EBITDA for Q4 was 58 million rupees, down from 93 million rupees in the same quarter last year. The EBITDA margin decreased to 8.30% from 13.04% year-over-year. Consolidated net profit for Q4 was 41 million rupees, up from 34 million rupees year-over-year, but down from 53 million rupees quarter-over-quarter. Q4 revenue was reported at 694 million rupees, compared to 712 million rupees in the same quarter last year.